GGrantIndex
Sort

40,608 grants matching prostate cancer

Defining the non-myogenic origins of pediatric rhabdomyosarcoma

$410,606
Mark Edward Hatley · St. Jude Children'S Research Hospital · R01 · FY2020 · CA

HIV induced anti-cancer HERV immunity in prostate, breast and colon cancers

$410,576
Douglas F Nixon · Weill Medical Coll Of Cornell Univ · R01 · FY2018 · CA

The structural and functional basis of MET exon 14 activation and acquired drug resistance

$410,565
Natalia Jura · University Of California, San Francisco · R01 · FY2021 · CA

ROLE OF OBESITY IN PROSTATE CANCER DEVELOPMENT

$410,563
Regents Of The University Of Minnesota · · FY2008 · Department of the Army

Inflammation and cancer treatment

$410,502
David Wink · Division Of Basic Sciences - Nci · ZIA · FY2014 · CA

Elucidating the Molecular Role of SYNCRIP in Prostate Cancer and AR Targeted Therapy Resistance

$410,480
Ping Mu · Yale University · R37 · FY2025 · CA

Primary Care Provider Education on Common Disease Genetics

$410,463
Ethylin Wang Jabs · Icahn School Of Medicine At Mount Sinai · U34 · FY2010 · DK

IDENIFY THE METABOLIC DEPENDENCIES OF OBESITY-ASSOCIATED AGGRESSIVE PROSTATE CANCER TO DEVELOP TAILORED IMAGING AND THERAPEUTIC APPROACHES

$410,442
Dana-Farber Cancer Institute, Inc. · · FY2016 · Department of the Army

EARLY DETECTION OF CANCER BY AFFINITY MASS SPECTROMETRY

$410,403
Eastern Virginia Medical School · U01 · FY2002 · CA

MS/AL Radiation Oncology Research Partnership

$410,351
James E. Clarkson · Singing River Health System · U54 · FY2011 · CA

Stroger Hospital of Cook County (SHCC) MU-NCORP Renewal

$410,325
Deimante Tamkus · Hektoen Institute For Medical Research · UG1 · FY2024 · CA

Hemostasis System in Tumor Growth and Metastasis

$410,317
Victoria Ploplis · University Of Notre Dame · P01 · FY2007 · HL

STAT Activation: Inactivation Cycle and Activated STAT3 in Cancer Cells

$410,248
James E Darnell · Rockefeller University · R01 · FY2007 · AI

Development of Drugs That Target Prostate Cancer

$410,239
William Douglas Figg · Division Of Basic Sciences - Nci · ZIA · FY2017 · CA

Development of Angiogenesis Inhibitors

$410,239
William Douglas Figg · Division Of Clinical Sciences - Nci · ZIA · FY2017 · CA

PSMA Directed Imaging of Prostate Cancer Focus on Androgen Receptor Dynamics

$410,209
Martin G Pomper · Johns Hopkins University · U01 · FY2015 · CA

Interaction of germline and somatic changes in PCa progression

$410,100
Wennuan Liu · Wake Forest University Health Sciences · R01 · FY2010 · CA

Roles of heat shock transcriptional factor 1 in cell proliferation independent of the heat shock response

$410,000
Jian Li · New York Medical College · R35 · FY2024 · GM

Roles of heat shock transcriptional factor 1 in cell proliferation independent of the heat shock response

$410,000
Jian Li · New York Medical College · R35 · FY2022 · GM

Leadership Component in Chemoprevention: Mouse Models of Human Cancer Consortium

$410,000
Cory Abate-Shen · Columbia University Health Sciences · U01 · FY2009 · CA

Roles of heat shock transcriptional factor 1 in cell proliferation independent of the heat shock response

$410,000
Jian Li · New York Medical College · R35 · FY2023 · GM

SOUTHWEST ONCOLOGY GROUP--SUMMARY

$409,950
Loyola University Chicago · U10 · FY2001 · CA

The structural and functional basis of MET exon 14 activation and acquired drug resistance

$409,930
Natalia Jura · University Of California, San Francisco · R01 · FY2020 · CA

Disrupting tumor/bone malignant interactions with multifunctional cytokine sonodelivery

$409,870
Marxa L. Figueiredo · Purdue University · R01 · FY2020 · CA

Genetic and Signaling Pathways in Epithelial Thyroid Cancer

$409,868
Matthew D Ringel · Ohio State University · P01 · FY2009 · CA